4//SEC Filing
Liu David Y 4
Accession 0001104659-22-024840
CIK 0001377121other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 7:25 PM ET
Size
7.5 KB
Accession
0001104659-22-024840
Insider Transaction Report
Form 4
Liu David Y
Chief Scientific Officer
Transactions
- Award
Common Stock
2022-02-15+10,000→ 68,657 total - Award
Stock Option (right to buy)
2022-02-15−60,000→ 60,000 totalExercise: $28.73Exp: 2032-02-14→ Common Stock (60,000 underlying)
Footnotes (3)
- [F1]Represents grant of restricted stock units payable solely in common stock that will vest in three annual installments on February 15, 2023, 2024 and 2025.
- [F2]Includes an aggregate of 403 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on September 9, 2021.
- [F3]The stock option vests in 48 equal monthly installments following the date of grant.
Documents
Issuer
Protagonist Therapeutics, Inc
CIK 0001377121
Entity typeother
Related Parties
1- filerCIK 0001675881
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 7:25 PM ET
- Size
- 7.5 KB